Onderneming Mersana Therapeutics, Inc.
Aandelen
MRSN
US59045L1061
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,49 USD | +4,42% | -7,23% | +93,53% |
19/03 | MERSANA THERAPEUTICS, INC. : JPMorgan Chase is niet langer negatief over het aandeel | ZM |
29/02 | MERSANA THERAPEUTICS, INC. : Truist Securities verhoogt advies van Neutraal naar Kopen | ZM |
Vakgebied
Aantal werknemers: 123
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugate
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 13-04-20 |
Director of Finance/CFO | 46 | 10-07-19 | |
David Mott
CHM | Chairman | 58 | 31-07-12 |
Timothy Lowinger
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-02-08 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02-03-15 |
Mohan Bala
PRN | Corporate Officer/Principal | - | 25-10-21 |
Chuck Miller
LAW | General Counsel | - | 31-08-20 |
Ashish Mandelia
AUD | Comptroller/Controller/Auditor | 50 | 01-07-19 |
Tushar Misra
PRN | Corporate Officer/Principal | 64 | 16-08-21 |
General Counsel | 50 | 26-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01-08-16 |
David Mott
CHM | Chairman | 58 | 31-07-12 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02-03-15 |
Andrew Hack
BRD | Director/Board Member | 50 | 06-01-17 |
Martin Huber
CEO | Chief Executive Officer | 64 | 13-04-20 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 05-09-17 |
Allene Diaz
BRD | Director/Board Member | 59 | 09-03-21 |
Willard Dere
BRD | Director/Board Member | 70 | 19-03-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 121 303 007 | 119 267 730 ( 98,32 %) | 0 | 98,32 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+93,53% | 545 mln. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,80% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Mersana Therapeutics, Inc. - Nasdaq
- Onderneming Mersana Therapeutics, Inc.